Message from the Chair, F. Bruder Stapleton, MD

Welcome to the Department of Pediatrics

F. Bruder Stapleton, MD

The Department of Pediatrics at the University of Washington's School of Medicine and Seattle Children's Hospital continues to be nationally recognized for its innovative clinical care, education and research. Our Department was ranked fifth among U.S. Departments of Pediatrics in 2016 by the U.S. News & World Report. Furthermore, our Nephrology, Hematology/Oncology, Neonatology and Gastroenterology divisions were all ranked among the top 10 U.S. programs and Cardiology and Pulmonary Medicine in the top 15. The Department.s faculty grew substantially in 2016. We now have over 500 physicians and scientists.

Educational programs continue to innovate in the Department of Pediatrics. In 2016 we launched a new curriculum as well as added new student sites in Idaho Falls, Idaho and Butte, Montana. The Graduate Medical Education Programs have added an additional permanent regional WWAMI resident spot in Missoula, Montana to begin in July 2017. Our Alaska Pediatric Residency Pathway has graduated its third class and at least 10 of our residents in the past three years have now elected to pursue pediatric practice opportunities in the state of Alaska. All of our Alaska graduates have gone into primary care. The Global Health Pathway continues to be an outstanding collaboration with the University of Nairobi and the University of Nairobi Residency Program. This past year the Ambassador Christopher Stevens Endowment created greater international exchanges. We were privileged to have Drs. Jemimah Mugo and Douglas Gaitho, Chief Residents from the University of Nairobi Department of Pediatrics visit our Department in November 2016. They enriched our residency program greatly.

Research in the Department continues to flourish. We reached a new high in grant funding in the past year with an annual total of over $70 million of NIH funding to the combined faculty at all research sites. The Immunotherapy Programs for treatment of childhood cancer under Dr. Michael Jensen continue to show tremendous success in Phase 1 and Phase 2 trials for acute leukemia. Drs. David Rawlings and Andrew Scharenberg are investigating gene and cellular therapies for other childhood conditions including severe combined immunodeficiency disease and diabetes. Dr. Dimitri Christakis in the Center for Child Health Behavior and Development has added a number of important investigators including Dr. Frederick Shic who has outstanding research programs in the field of autism.

Clinical programs have emerged with major innovations. Drs. David Suskind and Ghassan Wahbeh have developed impressive and promising new therapies for inflammatory bowel disease. Our outstanding childhood diabetes program continues to grow under the direction of Dr. Kate Ness in the Division of Pediatric Endocrinology and Diabetes. Our transplant programs remain among the best in the United States.

Of course, along with University of Washington and Seattle Children’s Hospital, we remain committed to our primary mission of improving the health of children throughout the world. We urge you to visit our website for additional information specific to your interest. Of course, along with University of Washington and Seattle Children.s Hospital, we remain committed to our primary mission of improving the health of children throughout the world. We urge you to visit our website for additional information specific to your interest.

Sincerely

F. Bruder Stapleton, MD

Professor and Chair, Department of Pediatrics
Ford/Morgan Endowed Chair in Pediatrics
Associate Dean, University of Washington School of Medicine
Chief Academic Officer and Senior Vice President
Pediatrician-in-Chief
Seattle Children's Hospital

Department of Pediatrics, RB.2.401
Seattle Children's Hospital
P.O. Box 5371
Seattle, WA 98105

Sites

University of Washington

1959 NE Pacific St.
Box 356320
Seattle, WA 98195-6320

Seattle Children's Hospital

4800 Sand Point Way NE
Seattle, WA 98105